Skip to main navigation Skip to search Skip to main content

Investigating the risks of Covid-19 vaccine supply chain

Jie Ma, Tommy K. H. Chan, Adrian Small

    Research output: Contribution to conferencePaperpeer-review

    125 Downloads (Pure)

    Abstract

    The development of the Covid-19 vaccines is promising to end the pandemic. However, having a safe and efficacy vaccine is one thing, ensuring them get delivered is quite another. The ‘Great Lockdown’ has not only largely restricted the movement of people and goods, but also caused significant impacts on the delivery of PPEs and other healthcare products. This study aims to understand how supply chains can mirror the demand for Covid-19 vaccinations. It employs the Protection Motiving Theory to investigate the relationships between participants’ information on vaccine availability and their decisions on vaccine uptake.
    Original languageEnglish
    Pages1-8
    Number of pages8
    Publication statusPublished - 7 Jul 2021
    Event28th EurOMA Conference: Managing the “new normal”: The future of Operations and Supply Chain Management in unprecedented times - Online: University of Sussex, Brighton, United Kingdom
    Duration: 5 Jul 20217 Jul 2021
    https://www.euroma21.org/

    Conference

    Conference28th EurOMA Conference
    Abbreviated titleEurOMA 2021
    Country/TerritoryUnited Kingdom
    CityBrighton
    Period5/07/217/07/21
    Internet address

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Covid-19 vaccine supply chain
    • supply chain risks
    • Protection Motiving Theory

    Fingerprint

    Dive into the research topics of 'Investigating the risks of Covid-19 vaccine supply chain'. Together they form a unique fingerprint.

    Cite this